Skip to main content
. 2010 May 12;2010(5):CD005006. doi: 10.1002/14651858.CD005006.pub4

2.9. Analysis.

2.9

Comparison 2 Conventional doxorubicin versus liposomal‐encapsulated doxorubicin (myocet), Outcome 9 Adverse effects: neutropenic fever (fever >=38, neutropenia grade 4, IV antibiotics and/or hospitalisation).